Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun;9(6):3946–3959. doi: 10.21037/tcr-20-2147

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2020 Translational Cancer Research. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

PMC Copyright notice

The characteristics of lncRNA FENDRR in non-small cell lung cancer (NSCLC). (A) The coding potential of FENDRR was analyzed by the PhyloCSF CSF analysis. MALAT1 (metastasis associated lung adenocarcinoma transcript 1) and XIST (X inactive specific transcript) served as noncoding RNA controls, and ACTB served as coding RNA control. The regions with a score greater than 0 (above the baseline) were predicted to be coding, while regions with a score less than 0 (below the baseline) were predicted to be noncoding; (B,C) the coding potential of FENDRR was analyzed by Coding Potential Calculator (CPC) and coding potential Assessment Tool (CPAT). MALAT1 and XIST served as noncoding RNA controls, and ACTB and GAPDH served as coding RNA controls; (D,E) subcellular fractionation experiment to show the localization of FENDRR in cells.